Chronic News and Research

RSS

Minority groups gear up to push for health care reform

Minorities are so far missing from the cacophony of voices - including doctors, insurers, industry lobbyists, and patient advocates - in the health-care reform debate, the Washington Post reports, even as they are "disproportionately represented among the poor and uninsured and could benefit the most from reform, and who are more likely than others to have chronic illnesses such as diabetes.

8 Oct 2009

New cancer drugs boost drug spending

Cancer treatments are on track to become the biggest driver of specialty pharmacy spending as its contribution to overall drug spending hit five percent for the first time in the first half of 2009, according to Medco Health Solutions, Inc.

8 Oct 2009

New Everyware Medical Gateway solution to remotely monitor treatment for diabetic patients

Eurotech Group, a leading supplier of embedded technologies, products, and systems, announces today the Everyware(TM) Medical Gateway designed to help physicians remotely monitor and adjust the treatment of their diabetes patients.

8 Oct 2009

Centric Health Corporation, PrevCan enter into an agreement to form a strategic alliance

Centric Health Corporation (TSX: CHH), a diversified healthcare company, today announced that it has entered into an agreement to form a strategic alliance with PrevCan, Inc. ("INTERxVENT Canada").

8 Oct 2009

New Leaf Brands' initiative to find cure for MS, will sponsor a participating team for bike ride event

New Leaf Brands, a wholly owned subsidiary of Baywood International, Inc. (OTCBB: BAYW) ("Company"), today announced that the Company will sponsor a participating team in the Multiple Sclerosis/Tappan Zee Bike Ride taking place on Sunday, October 18, 2009 in Tarrytown, New York.

8 Oct 2009

Employers make substantial changes to employees' medical plan for 2010

As employees flip through their open enrollment packets, they may notice substantial changes to their medical plan for 2010, from increases to employee contributions to introducing a wellness program, according to the 2009 Benefits & Talent Survey by Aon Consulting, the human capital consulting firm of Aon Corporation.

8 Oct 2009

Dominion Diagnostics enhances laboratory testing procedure for chronic opioid pharmacotherapy

Only a short time after introducing its newly developed and validated tapentadol assay, Dominion Diagnostics (Dominion) is pleased to announce an important enhancement to another clinical laboratory test.

8 Oct 2009

Researchers find link between obesity and common mental disorders

Doctors should pay more attention to the link between common mental illness and obesity in patients because the two health problems are closely linked, according to researchers at the University of Adelaide.

8 Oct 2009

AMAG Pharmaceuticals to present three abstracts at ASN Renal Week meeting

AMAG Pharmaceuticals, Inc. today announced that three abstracts have been accepted for presentation at the American Society of Nephrology (ASN) Renal Week meeting being held October 27-November 1, 2009 in San Diego, CA.

8 Oct 2009

Phadia launches new, advanced assays for accurate diagnosis of celiac disease

Phadia Inc., worldwide leaders in the development, manufacturing and marketing of complete blood test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases, today announced the launch of a two new, highly -reliable assays to support the accurate diagnosis of celiac disease.

8 Oct 2009

Multi-center Lung Genomics Research Consortium to study fatal lung diseases

Researchers at five research centers have been awarded an $11 million, two-year grant from the National Heart Lung and Blood Institute as part of the NIH Recovery Act that will allow a team of national scientists to delve deeply into the biology of two fatal lung diseases for which there are few therapeutic options.

8 Oct 2009

Triple therapy may benefit patients with chronic obstructive pulmonary disease

Patients with moderate to severe chronic obstructive pulmonary disease (COPD) can benefit from triple therapy that includes a long-acting β-agonist (LABA), an inhaled corticosteroid (ICS) and an anti-muscarinic agent, according to researchers in Germany.

8 Oct 2009

User's guide to refocus and reform American health care

Health Care Will Not Reform Itself: A User's Guide to Refocusing and Reforming American Health Care, is the latest installment from acclaimed author and health care industry power George C. Halvorson.

8 Oct 2009

U.N. appeals for $74m to provide emergency assistance in the Philippines; health-effects of other natural disasters

The U.N. on Tuesday launched an appeal for $74 million "to provide emergency assistance to hundreds of thousands of victims of two catastrophic typhoons that have struck the Philippines in less than two weeks," VOA News reports (Schlein, 10/6).

8 Oct 2009

NHLBI awards $11 million to research on the biology of two fatal lung diseases

Researchers at National Jewish Health and four other research centers have been awarded an $11 million, two-year grant from the National Heart Lung and Blood Institute as part of the NIH Recovery Act that will allow a team of national scientists to delve deeply into the biology of two fatal lung diseases for which there are few therapeutic options.

8 Oct 2009

HHS awards a five-year $2 million grant to BayCare Behavioral Health

BayCare Behavioral Health and the Homeless Emergency Project have received a five-year grant of $400,000 for each year for a total of $2 million from the U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment (CSAT).

8 Oct 2009

Zenvia patent application: AVANIR Pharmaceuticals receives USPTO "Notice of Allowance"

AVANIR Pharmaceuticals, Inc. today announced that it has received a “Notice of Allowance” from the United States Patent and Trademark Office (USPTO) announcing that it intends to grant the Company a new patent, extending the period of commercial exclusivity for its lead drug candidate Zenvia™ well into 2025.

8 Oct 2009

MENA's diabetes action plan to improve the prevention, treatment and care of diabetes

International Diabetes Federation Middle East and North Africa Region (MENA) today launched a diabetes action plan, marking a major step forward towards optimal disease management in type 2 diabetes. The MENA action plan aims to improve the prevention, treatment and care of diabetes, which has reached epidemic proportions in the region and has overtaken wider communicable diseases as a health risk.

8 Oct 2009

Relypsa commences patient enrollment in Phase 2b clinical trial of RLY5016 for treating hyperkalemia

Relypsa, Inc., today announced the initiation of patient enrollment in the PEARL-HF study, a Phase 2b clinical trial of the company’s lead compound, RLY5016. A novel potassium binder designed for chronic use, RLY5016 is being evaluated in the prevention and treatment of hyperkalemia, for which there are no current satisfactory treatments.

7 Oct 2009

Diabetech and Cinterion Wireless Modules announce their collaboration on fourth generation GlucoMON platform

Cinterion Wireless Modules, the global leader in cellular machine-to-machine (M2M) communication modules, and Diabetech, the leader in patient-centric health care programs, today announced their collaboration on the fourth generation GlucoMON® platform, the world’s easiest-to-use wireless diabetes management system designed to help the over 220 million people worldwide struggling to manage the global diabetes and pre-diabetes pandemic.

7 Oct 2009

Chronic News and Research

Minority groups gear up to push for health care reform

New cancer drugs boost drug spending

New Everyware Medical Gateway solution to remotely monitor treatment for diabetic patients

Centric Health Corporation, PrevCan enter into an agreement to form a strategic alliance

New Leaf Brands' initiative to find cure for MS, will sponsor a participating team for bike ride event

Employers make substantial changes to employees' medical plan for 2010

Dominion Diagnostics enhances laboratory testing procedure for chronic opioid pharmacotherapy

Researchers find link between obesity and common mental disorders

AMAG Pharmaceuticals to present three abstracts at ASN Renal Week meeting

Phadia launches new, advanced assays for accurate diagnosis of celiac disease

Multi-center Lung Genomics Research Consortium to study fatal lung diseases

Triple therapy may benefit patients with chronic obstructive pulmonary disease

User's guide to refocus and reform American health care

U.N. appeals for $74m to provide emergency assistance in the Philippines; health-effects of other natural disasters

NHLBI awards $11 million to research on the biology of two fatal lung diseases

HHS awards a five-year $2 million grant to BayCare Behavioral Health

Zenvia patent application: AVANIR Pharmaceuticals receives USPTO "Notice of Allowance"

MENA's diabetes action plan to improve the prevention, treatment and care of diabetes

Relypsa commences patient enrollment in Phase 2b clinical trial of RLY5016 for treating hyperkalemia

Diabetech and Cinterion Wireless Modules announce their collaboration on fourth generation GlucoMON platform

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News